Skip to main content
Equibles

SBMFF · Sino Biopharmaceutical Limited/ADR

Track SBMFF — free

Use SBMFF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SBMFF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.70 At close · Sep 17
Rebalance outlook locked
Market Cap
$12.47B
Shares
17.82B

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.70 Open$0.70 Day$0.70–0.70 52W close$0.59–1.16 Avg vol 30d2K Short int25.7M · 0.1% float · 999+d Short vol100% DataJan 2020–Sep 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
1.3%
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-38.5%
Trailing year
Short interest
0.1%
Latest settlement · 999+ days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.4 · calm Equity put/call 0.52
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +23%
above
Price vs 50-day avg −18%
below
RSI (14) 45
neutral
MACD trend Positive
52-week position 19%
mid-range
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Neutral
1-month return −16%
trailing
6-month return +106%
trailing
YTD return −20%
this year
Relative strength +88%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.14% of float · ▼ -7.1% MoM · 1000.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Squeeze score 43
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 102%
annualized · 1-yr
Max drawdown −52%
past year
ATR 4.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+23% Bullish
Price vs 50-day avg
−18% Bearish
RSI (14)
45 Neutral
MACD trend
Positive Bullish
52-week position
19% Neutral
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.14% of float · ▼ -7.1% MoM · 1000.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $1 Now $1 · 19% Range high $1
vs 200-day avg +23% vs 50-day avg -18%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SBMFF
Sino Biopharmaceutical Limited/ADR
this stock
$12.47B — — — 0.1%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $130.06B +13.9% +46.2% 29.9 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
 $79.83B +2.3% +20.8% 19.2 2.5%
ARGX
Argenx SE
 $60.93B +18.4% — — 2.0%
CSLLY
Csl Ltd
 $59.64B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Falling
Shares short
25.7M
Days to cover
1000.0d
Change
-2.0M sh
View
Short Volume
Short vol %
100%
As of
Sep 11, 2026
Short Total
View
Off-Exchange
Off-exchange %
100.0%
Week of
Aug 3, 2026
Off-exch Lit
View

Performance

5D 20D 120D MTD YTD
SBMFF +7.7% -15.5% +106.2% -5.0% -19.6%
SPY +0.6% -0.8% +18.2% -0.6% +11.8%
vs SPY +7.1% -14.7% +88.0% -4.4% -31.4%

Capital returns

Latest dividend
$0.009 / share · ex Sep 1, 2026
Raised 80%
Paid (TTM)
$0.009 / share · 1 payout
Dividend yield (TTM, derived)
— · history filling in

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1604982 Visit website